Skip to main content
Clinical Trials/EUCTR2008-007319-33-GB
EUCTR2008-007319-33-GB
Active, not recruiting
Not Applicable

Do genes predict response to treatment in age-related macular degeneration? - ARMD pharmacogenetics

eeds Teaching Hospitals NHS Trust0 sitesNovember 23, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
eeds Teaching Hospitals NHS Trust
Status
Active, not recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 23, 2010
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
eeds Teaching Hospitals NHS Trust

Eligibility Criteria

Inclusion Criteria

  • Written informed consent
  • Age over 65 years
  • Choroidal neovascularisation secondary to Age\-related macular degeneration (ARMD)
  • Lesion size less than 5400 microns
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Lack of informed consent
  • Lesion size greater than 5400 microns at baseline
  • Other ocular pathology likely to influence visual acuity after treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials